Geir Lund • 1958 • Greåker • 26 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
V VITAMAX AS	Managing Director/CEO	-	2,997,792	50 % indirectly
L LUNDS KLINIKK AS	Managing Director/CEO	1,007,229	75,557	50 % directly
B BIOPHARMA AS	Managing Director/CEO	24,069,305	5,582,290	40.32 % indirectly
P PHARMATECH AS	Managing Director/CEO	404,181,231	21,362,866	40.32 % indirectly
B BIOSAN AS	Managing Director/CEO	5,760,752	9,342,541	40.32 % indirectly
G GME LUND HOLDING AS	Managing Director/CEO	-	15,881,277	40.32 % directly
M MULTILAB ØSTFOLD AS	Managing Director/CEO	4,971,801	2,849,095	40.32 % indirectly
F FARMATEKET AS	Managing Director/CEO	78,057	417,273	40.32 % indirectly
L LUND EIENDOM FREDRIKSTAD AS	Managing Director/CEO	8,160,852	25,473,169	40.32 % indirectly
B BIO-SAN INTERNATIONAL AVD ØSTFOLD G Lund	Managing Director/CEO	-	-	-

Boards

Name	Role	Total operating income	Total equity	Shares
P PHARMAPAC AS	Contact Person	-	29,518	50 % directly
V VITAMAX AS	Chairman	-	2,997,792	50 % indirectly
L LUNDS KLINIKK AS	Chairman	1,007,229	75,557	50 % directly
B BIOPHARMA AS	Chairman	24,069,305	5,582,290	40.32 % indirectly
P PHARMATECH AS	Chairman	404,181,231	21,362,866	40.32 % indirectly
B BIOSAN AS	Chairman	5,760,752	9,342,541	40.32 % indirectly
G GME LUND HOLDING AS	Board Member	-	15,881,277	40.32 % directly
M MULTILAB ØSTFOLD AS	Chairman	4,971,801	2,849,095	40.32 % indirectly
F FARMATEKET AS	Chairman	78,057	417,273	40.32 % indirectly
L LUND EIENDOM FREDRIKSTAD AS	Chairman	8,160,852	25,473,169	40.32 % indirectly
B BIO-SAN INTERNATIONAL AVD ØSTFOLD G Lund	Holder	-	-	-
B BIO-SAN ANS	Contact Person	-	-	-
L LAVENDULA ANS	Contact Person	-	-	-

Last update: Apr 13, 2023

Related industries5

Wholesale and retail trade; repair of motor vehicles and motorcycles
Manufacturing
Professional, scientific and technical activities
Human health and social work activities
Real estate activities

Direct relationships4

MK
Mette Kristin Lund1959
PHARMAPAC AS, BIOPHARMA AS, PHARMATECH AS, BIOSAN AS, GME LUND HOLDING AS, BIO-SAN ANS, VITAMAX AS, MULTILAB ØSTFOLD AS, FARMATEKET AS, LAVENDULA ANS
ML
Markus Wilhelmsen Lund1979
BIOPHARMA AS, GME LUND HOLDING AS
ES
Eline Lund Sælid1981
GME LUND HOLDING AS, LUNDS KLINIKK AS
GA
Geir Andreas Lund1987
GME LUND HOLDING AS

Shares owned by Geir Lund

Name	Share class	Total operating income	Total equity	Share
P PHARMAPAC AS	Ordinære aksjer	0	29,518	50 % directly
L LUNDS KLINIKK AS	Ordinære aksjer	1,007,229	75,557	50 % directly
V VITAMAX AS		0	2,997,792	50 % indirectly
G GME LUND HOLDING AS	Ordinære aksjer	0	15,881,277	40.32 % directly
B BIOPHARMA AS		24,069,305	5,582,290	40.32 % indirectly
P PHARMATECH AS		404,181,231	21,362,866	40.32 % indirectly
B BIOSAN AS		5,760,752	9,342,541	40.32 % indirectly
M MULTILAB ØSTFOLD AS		4,971,801	2,849,095	40.32 % indirectly
F FARMATEKET AS		78,057	417,273	40.32 % indirectly
L LUND EIENDOM FREDRIKSTAD AS		8,160,852	25,473,169	40.32 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024